The U.S. Food and Drug Administration (FDA) has authorized the emergency use of the Pfizer-BioNTech COVID-19 vaccine for children ages 5 through 11. The Pfizer-BioNTech COVID-19 vaccine for children in this age group is administered as a two-dose primary series, three weeks apart, but is a lower dose (10 micrograms) than that used for ages 12 older (30 micrograms). The Centers for Disease Control and Prevention (CDC)...
This content is restricted to members.
